Previous close | 66.51 |
Open | 66.45 |
Bid | 65.39 x 1000 |
Ask | 66.01 x 3100 |
Day's range | 65.58 - 66.60 |
52-week range | 53.63 - 71.70 |
Volume | |
Avg. volume | 6,887,517 |
Market cap | 204.313B |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.36 |
Earnings date | N/A |
Forward dividend & yield | 1.44 (2.28%) |
Ex-dividend date | 24 Feb 2022 |
1y target est | 71.80 |
The EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to AstraZeneca's (AZN) cancer drugs, Enhertu and Lynparza, for treating certain patients with breast cancer.
UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt are part of Zacks top Analyst Blog.
Yahoo Finance’s Jared Blikre breaks down how markets opened on Monday.